Home

Joshua A Kazam

CIK 1221355 · President & CEO · last filed 2026-06-23

Joshua A Kazam is a President & CEO who has filed 59 SEC Form 4 insider transactions across 11 companies since 2008. The most recent filing, for ALLO, was dated Jun 23, 2026. Across all open-market trades the lifetime net is +$306.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $701.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$701.3K

Companies

11

Total Filings

59

Lifetime Open-Market Net

$306.5K

Filer Profile

Reported Address
689 5TH AVENUE
12TH FLOOR
NEW YORK, NY 10022
Formerly Known As
KAZAM JOSHOA A (2003–2007)
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALLO Director 398,463 $1.76 $701.3K $189.0K 20 2026-06-23
Kronos Bio, Inc. (KRON) Delisted Director 0 $0.88 $0 $0 7 2025-06-20
Latch, Inc. (TSIAW) Delisted 30,000 $2.42 $72.6K $0 1 2021-06-07
Tishman Speyer Innovation Corp. II (TSIBU) Delisted Director 25,000 $10.04 $251.0K $0 1 2021-02-16
DraftKings Holdings Inc. (DEACW) Delisted Director — — — $0 1 2019-12-31
Target Hospitality Corp. (EAGLW) Delisted Director 10,000 — — $101.7K 3 2019-03-05
Target Hospitality Corp. (EAGLU) Delisted Director — — — $0 1 2018-01-18
CAPR Director — $8.30 — $0 3 2018-01-04
Kite Pharma, Inc. (KITE) Delisted Director 4,360 — — $0 3 2017-06-22
CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted Chief Executive Officer 1,493,758 — — $0 3 2011-05-12
CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted Chief Executive Officer 7,219 $13.96 $100.8K $15.9K 8 2009-07-23

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 ALLO Mixed +47,700 $0 EDGAR
2025-12-22 ALLO Exer (M) +47,700 $0 EDGAR
2025-06-23 ALLO Grant (A) — $0 EDGAR
2025-06-20 Kronos Bio, Inc. (KRON) Delisted Mixed −94,481 -$53.9K EDGAR
2024-06-26 Kronos Bio, Inc. (KRON) Delisted Grant (A) — $0 EDGAR
2024-06-07 ALLO Grant (A) — $0 EDGAR
2023-06-26 Kronos Bio, Inc. (KRON) Delisted Grant (A) — $0 EDGAR
2023-06-15 ALLO Grant (A) — $0 EDGAR
2022-06-29 Kronos Bio, Inc. (KRON) Delisted Grant (A) — $0 EDGAR
2022-06-17 ALLO Grant (A) +44,178 $0 EDGAR
Showing 1–10 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.